drugset / Trial / NCT06200883

Effects of a Nutraceutic Compound on Cognitive Impairment

NCT06200883

Phase 4 Completed 58 enrolled Federico II University
RandomizedParallel-groupDouble-blindPrevention

Summary

The study is designed to evaluate the effects of choline bitartrate on cognitive impairment in frailty patients. The study will analyze the impact of 4 weeks treatment randomized with a nutraceutical compound in a double-blind randomized placebo controlled trial. The investigators will also assess cognitive frailty.

Timeline

Start
2022-09-01
Primary completion
2023-09-01
Completion
2023-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Choline Bitartrate Small molecule 1.2 g Oral